GH
BIVV

GAM Holding’s Bioverativ Inc. Common Stock BIVV Stock Holding History

GAM Holding’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23,800
Closed -$1.28M – 929
2017
Q4 		$1.28M Buy
23,800
+425
+2% +$23.3K 0.04% 508
2017
Q3 		$1.33M Sell
23,375
-1,078
-4% -$63.1K 0.06% 317
2017
Q2 		$1.47M Sell
24,453
-1,597
-6% -$90.9K 0.02% 561
2017
Q1 		$1.42M Buy
+26,050
New +$1.28M 0.02% 582

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

GAM Holding's BIVV Position: Q1 2018 in Review

GAM Holding sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 23,800 shares — an estimated $1.28M sold.

GAM Holding first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.47M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • GAM Holding reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • GAM Holding sold 23,800 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.28M.
  • GAM Holding first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • GAM Holding's Bioverativ Inc. Common Stock position peaked at $1.47M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on GAM Holding's 13F filing for Q1 2018, filed 15 May 2018.